Latest News and Press Releases

SAN DIEGO, CA--(Marketwired - Oct 28, 2013) - Aegis Therapeutics LLC is proud to announce it is celebrating its 10-year anniversary on October 31, 2013. Aegis was founded by a renowned...

SAN DIEGO, CA--(Marketwired - Oct 9, 2013) - Aegis Therapeutics LLC announced today that it has been awarded its first patent for non-invasive delivery of a protein drug to the central nervous...

SAN DIEGO, CA--(Marketwired - Sep 4, 2013) - Two "super generic" drugs utilizing Aegis Therapeutics Intravail technology for treatment of migraine headaches and seizures are rapidly advancing...

SAN DIEGO, CA--(Marketwired - Aug 13, 2013) - Aegis Therapeutics LLC announced today that it has been awarded a third patent for fast acting formulations of triptans, a widely used class of drugs...

SAN DIEGO, CA--(Marketwired - Apr 2, 2013) - Concerns about the economic viability of biosimilars center around the high development cost relative to small molecule generics, and the difficulty of...

SAN DIEGO, CA--(Marketwire - Dec 11, 2012) - Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 8,329,220 providing proprietary compositions for absorption-enhancing...

SAN DIEGO, CA--(Marketwire - Sep 24, 2012) -  Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 8,268,791 providing fast acting formulations for triptans, a class...

SAN DIEGO, CA--(Marketwire - Jul 24, 2012) -  Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 8,226,949 providing broad protection for stabilized formulations of...

SAN DIEGO, CA--(Marketwire - May 21, 2012) - Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 8,133,863 providing broad protection for pharmaceutical composition of...

SAN DIEGO, CA--(Marketwire - May 16, 2012) - Aegis Therapeutics LLC announced today that it has been awarded a second patent, U.S. Patent, No. 8,173,594, providing PTH and PTH analog compositions...